Bio-Techne (TECH) Long-Term Investments (2010 - 2026)
Bio-Techne (TECH) recorded quarterly Long-Term Investments of $231.0 million in Q1 2026, down 1.71% quarter-over-quarter from $235.0 million in Q4 2025, and up 1440.19% on a YoY basis from $15.0 million in Q1 2025.
Bio-Techne (TECH) Long-Term Investments (2010 - 2026) Analysis & Trends
Bio-Techne's Long-Term Investments history runs 14 years deep, the most recent figure standing at $231.0 million for Q1 2026.
- In Q1 2026, Long-Term Investments rose 1440.19% year-over-year to $231.0 million; the TTM figure through Mar 2026 stood at $231.0 million (up 1440.19% YoY), while the FY2025 annual figure was $236.0 million, down 2.62% from the prior year.
- Long-Term Investments was $231.0 million for Q1 2026 at Bio-Techne, down from $235.0 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $257.0 million in Q1 2023 to a low of $15.0 million in Q4 2024.
- Historically, Long-Term Investments has averaged $174.2 million across 5 years, with a median of $235.5 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Long-Term Investments tumbled 93.99% in 2024, then surged 1466.91% in 2025.
- A 5-year view of Long-Term Investments shows it stood at $25.0 million in 2022, then jumped by 898.92% to $249.7 million in 2023, then sank by 93.99% to $15.0 million in 2024, then soared by 1466.91% to $235.0 million in 2025, then decreased by 1.71% to $231.0 million in 2026.
- The last three Long-Term Investments figures came in at $231.0 million (Q1 2026), $235.0 million (Q4 2025), and $234.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | 231.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 231.03 Mn |
| Dec 31, 2025 | 235.04 Mn |
| Sep 30, 2025 | 234.93 Mn |
| Jun 30, 2025 | 235.98 Mn |
| Mar 31, 2025 | 15.00 Mn |
| Dec 31, 2024 | 15.00 Mn |
| Sep 30, 2024 | 241.31 Mn |
| Jun 30, 2024 | 242.34 Mn |
| Mar 31, 2024 | 247.98 Mn |
| Dec 31, 2023 | 249.73 Mn |
| Sep 30, 2023 | 251.64 Mn |
| Jun 30, 2023 | 255.86 Mn |
| Mar 31, 2023 | 257.00 Mn |
| Dec 31, 2022 | 25.00 Mn |
| Sep 30, 2022 | 25.00 Mn |
| Jun 30, 2022 | 25.00 Mn |
| Jun 30, 2020 | 6.60 Mn |
| Jun 30, 2018 | 2.61 Mn |
| Mar 31, 2018 | 24.18 Mn |
| Dec 31, 2017 | 40.39 Mn |